thoracoscopic lung surgery
Conditions
Interventions
Experimental Group:PCIA uses esketamine
Sponsors
Gansu Provincial Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Thoracic patients undergoing thoracoscopic lung surgery; 2. Aged 18 to 65 years; 3. ASA classification I ~ II; 4. BMI18-30; 5. Clear consciousness, basic reading comprehension ability, normal vision and hearing; 6. No history of mental illness or cognitive dysfunction in the past, and can express their feelings in language; 7. Voluntarily participate in this study, understand and sign the informed consent form, and cooperate with those who complete the intervention and assessment.
Exclusion criteria
Exclusion criteria: 1. Those who are allergic to or have contraindications to the use of drugs and excipients during surgery and postoperative analgesia; 2. Participate in other clinical studies within 3 months before being enrolled in this study; 3. Those with dysfunction of important organs such as the heart, liver and kidney; 4. Being pregnant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SF-MPQ questionnaire score;PHQ-9 questionnaire score;pain score; | — |
Secondary
| Measure | Time frame |
|---|---|
| recovery quality;rescue analgesia;adverse reactions; | — |
Countries
China
Contacts
Public ContactYan Wenjun
Gansu Provincial Hospital
Outcome results
None listed